Your browser doesn't support javascript.
loading
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial.
Lee, Nancy Y; Harris, Jonathan; Kim, John; Garden, Adam; Mechalakos, James; Pfister, David G; Chan, Anthony T C; Hu, Kenneth; Colevas, A Dimitrios; Frank, Steven; Shenouda, George; Bar-Ad, Voichita; Waldron, John N; Harari, Paul M; Raben, Adam; Torres-Saavedra, Pedro; Le, Quynh-Thu.
Affiliation
  • Lee NY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Harris J; Statistics and Data Management Center, NRG Oncology, American College of Radiology, Philadelphia, Pennsylvania.
  • Kim J; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Garden A; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Mechalakos J; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Pfister DG; Department of Medicine Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chan ATC; Department of Clinical Oncology, Chinese University of Hong Kong, Shatin, Hong Kong.
  • Hu K; Department of Radiation Oncology, New York University Langone Medical Center, New York, New York.
  • Colevas AD; Accrual for State University of New York Health Science Center, Brooklyn, New York.
  • Frank S; Department of Medicine, Stanford University, Stanford, California.
  • Shenouda G; Accruals for University of California, San Francisco.
  • Bar-Ad V; Department of Radiation Oncology, MD Anderson Cancer Center, Houston, Texas.
  • Waldron JN; Department of Radiation Oncology, McGill University, Montreal, Quebec, Canada.
  • Harari PM; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Raben A; Department of Radiation Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, Canada.
  • Torres-Saavedra P; Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison.
  • Le QT; Helen F. Graham Cancer Center, Christiana Care Health System, Newark, Delaware.
JAMA Netw Open ; 6(6): e2316094, 2023 06 01.
Article de En | MEDLINE | ID: mdl-37266942

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rhinopharynx / Cisplatine Type d'étude: Clinical_trials / Prognostic_studies Limites: Adolescent / Adult / Humans / Male / Middle aged Langue: En Journal: JAMA Netw Open Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du rhinopharynx / Cisplatine Type d'étude: Clinical_trials / Prognostic_studies Limites: Adolescent / Adult / Humans / Male / Middle aged Langue: En Journal: JAMA Netw Open Année: 2023 Type de document: Article Pays de publication: États-Unis d'Amérique